The Fellowships enable the recipient to concentrate on developing the commercial potential of their research, whilst also receiving formal training in relevant business skills.
Funded by BBSRC and delivered by The Royal Society of Edinburgh, Enterprise Fellowships are designed to encourage the development of a new business, building on previously funded BBSRC research, around a technological idea developed by the Fellow (either individually or with others) and within which the Fellow would be expected to play a leading (though not necessarily the leading) role. This award is of particular relevance to individuals and ideas who previously received BBSRC Follow-on Funding (although not exclusively).
Training and support
Enterprise Fellowships are designed to enable the recipient to focus on the development of their research into a commercial proposition, through business training tailored to the individual project, access to business professionals with a proven track record of commercial success and funding to cover the costs of attending conferences and trade shows.
- A year’s salary to provide time to develop a full business plan and seek investment
- Access to mentors, business experts and professional advisors
- Tailored business training to help develop the required skills
All Enterprise Fellows become part of the RSE Entrepreneurs Club, an exclusive group that includes investors, past awardess, business experts, professeional advisors and RSE fellows. All current Enterprise Fellows are asked to deliver two presentations during their Fellowship year, where they are able to provide an outline of progress on their business development plans and to receive feed back from the club members.
What Enterprise Fellows say
The programme has already led to holders of fellowships taking up chief executive, technical director or other key player posts in some of the UK's exciting new high technology companies.
Watch a video where BBSRC-funded Enterprise Fellow Dr Margaret Anne Craig describes her experience founding Clyde Biosciences. You can also read a Q&A with her: Profile feature – Margaret Craig.
Dr Andrew Almond - C4X Discovery Limited (previously Conformetrix)
Dr Almond's unique technology, to determine the dynamic 3D shapes of drug molecules, is the culmination of a large body of work produced during a BBSRC David Phillips Fellowship. Within the space of 3 years, Dr Almond's research has gone from laboratory concept to the edge of commercial reality, which promises to have a substantial contribution to drug discovery and, ultimately, patient health.
His research group's discovery of the flexible 3D molecular shape of hyaluronan quickly led to a UK patent and the all-important 'proof of concept' that their new methodology could be generalised to any small flexible molecules, such as antibiotics and hormones With the support of two Follow on Fund awards and a BBSRC/RSE Enterprise Fellowship, Dr Almond has made rapid progress towards commercialisation and, with his colleague Dr Charles Blundell, formed the spin out company Conformetrix to exploit the technology. They went on to raise seed funding from Aquarius Equity Partners.
For more information about C4X Discovery Limited (previously Conformetrix) visit their website (see external links).